PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.\', \'Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.\', \'Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands.\', \'Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, Netherlands.\', \'Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.\', \'Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.\', \'Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.\', \'Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.\', \'Department of Intensive Care, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Intensive Care, Erasmus MC, Rotterdam, Netherlands.\', \'School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.719115
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34367187
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34367187>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34367187>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all